Hagop Youssoufian, Founder and Principal at Youssoufian Consulting, LLC, shared a post on LinkedIn:
“Excited by TREOS BIO’s collaboration in colorectal cancer with Charité – Universitätsmedizin Berlin and Shanghai Junshi Biosciences Co Ltd evaluating its lead product candidate, a multi-epitope, off-the-shelf tumor vaccine, in combination with an anti-PD1 and standard-of-care chemotherapy – an essential next step for advancing the care of these patients.”
M0re posts featuring Hagop Youssoufian.